A factor has been purified that specifically facilitates RNA chain elongation in a chromatin context; the properties of this factor help to define the challenges that lie ahead in understanding how RNA polymerase manages to transcribe DNA that is packaged into chromatin.
Making a faithful and full-length RNA transcript of a double-stranded DNA template is a complex task, largely because of the requirement for processivity and retention of register during RNA chain elongation. Dispersal of the polymerase and its nascent transcript into the threedimensional space of the cell is effectively irreversible, and must therefore be prevented from occurring (although displacement in the one-dimensional space of the DNA thread is reversible and therefore tolerable) [1, 2] . The nascent RNA chain must also be held in the transcription complex in such a way that the register between transcript and template is retained, even in the face of repetitive DNA sequences. Nevertheless, it is also necessary to be able to abandon processivity on cue, that is, upon encounter of DNA sequences or DNA-bound proteins signaling termination of transcription [2, 3] .
DNA-dependent RNA polymerases are adapted to these requirements, and to functioning in concert with protein factors and RNA structures to make the RNA chain elongation and termination part of the regulation of gene activity. In bacteria (Escherichia coli, that is), RNA chain elongation is modulated by a number of accessory proteins, including ρ, NusA, NusB, NusG, NusE (S10 ribosomal protein), GroA and GroB. Bacterial RNA chain elongation responds to diverse cellular regulators, including the Current Biology translational machinery and nucleotide-generating, as well as nucleotide-consuming, metabolism. A number of viral regulatory proteins, of which phage λ, N and Q proteins are the best-studied examples, also modulate RNA chain elongation as well as termination [3] [4] [5] .
The expectation that RNA chain elongation in eukaryotes cannot be any less complex than it is in bacteria is in the process of more than ample fulfillment. The currently identified transcript elongation factors of RNA polymerase II include TFIIF, SII (the functional homologue of the bacterial GreB and GreA proteins), SIII/elongin, ELL, P-TEF b ('positive transcription elongation factor'), and the transcript release factor-2 [3, 6] . What all these factors have in common is that they have been identified through biochemical analysis of transcription of naked DNA templates. In cells, however, transcription by polymerase II takes place in the confining context of chromatin [7] [8] [9] . The special interest of a recent paper by Orphanides et al. [10] is that it documents the identification and purification from human cells of a two-protein complex, FACT, which facilitates RNA chain elongation by human polymerase II specifically on a chromatin template (hence the acronym, for a transcription component that 'facilitates chromatin transcription').
The basic observations leading to the search for FACT ( Figure 1 ) involved in vitro transcription of DNA containing GAL4-binding sites upstream of a polymerase II promoter linked to a transcription unit consisting of an approximately 400 base pair 'G-less cassette' (DNA designed to be transcribed with ATP, CTP and UTP only). A crude Drosophila embryo extract assembles this DNA into nucleosome arrays that are regularly spaced in the manner of natural chromatin. In the presence of ATP, the Drosophila extract mobilizes and ultimately remodels this chromatin around the transcriptional activator GAL4-VP16 -a fusion protein consisting of the DNA-binding domain of yeast GAL4 linked to the activation domain of the viral protein VP16 -in such a way that the promoter becomes accessible to the transcription machinery (Figure 2a , top line).
As is already well known, transcription of this chromatinloaded DNA with a crude nuclear extract from HeLa (human) cells absolutely requires the transcriptional activator GAL4-VP16. The key result was obtained when, instead of using the crude HeLa system, the experiment was repeated with purified polymerase II general transcription factors (TFIIB, TFIID, TFIIE, TFIIF, TFIIH and TFIIA), the activator-responsive factor PC-4 and polymerase II. It is well known that naked DNA is transcribed by this combination of components, and that this transcription is activated by GAL4-VP16. But chromatin did not yield the anticipated transcripts. Why not?
It turns out that, in the experimental set-up employed by Orphanides et al. [10] , polymerase II does get recruited to the promoter, which opens as normal, allowing short transcripts to be formed on the chromatin template by the purified, simplified and reconstituted transcription system. But the polymerase gets stuck when the nascent RNA chains reach lengths of approximately 20-60 nucleotides.
Orphanides et al. [10] then fractionated the HeLa cell nuclear extract to find the activity that allows polymerase II to elongate transcripts on a chromatin template. In this way, they purified FACT, the factor that counteracts the chromatin-mediated block to transcript elongation.
FACT was found to consist of two co-purifying proteins, of molecular weights approximately 140 kDa and 80 kDa. FACT acts purely to permit transcript elongation, without apparently interacting with the transcriptional activator. It does not require ATP hydrolysis for its action, nor does it require the TFIIF and TFIIS elongation factors as coeffectors. Because its activation is effectively competed by naked DNA, FACT is thought to be a DNA-binding protein. Orphanides et al. [10] hazard the guess that FACT works in a stoichiometric fashion, with near-equivalence to the nucleosomes. Its fate during transcript elongation remains to be determined.
A technically demanding variation on these experiments yielded a second interesting outcome. Ternary transcription complexes with short -15 and 18 nucleotides long -nascent RNA chains were first formed on naked DNA, purified and then used to assemble chromatin with purified histones (by salt-step dilution and dialysis). It was found that, with this highly purified chromatin and highly purified transcription machinery, the elongation of RNA chains is almost immediately blocked (when a mere ten or fewer nucleotides were added to the nascent RNA chains). FACT relieves this block also, but does not prevent stalling further along the DNA template, when the nascent RNA chains have advanced no more than about 50-150 nucleotides (that is, about a nucleosome's worth of DNA, or less).
That FACT generates such a modest RNA extension in conjunction with the most purified components clearly raises the possibility that it might be specialized for dealing only with the promoter-proximal nucleosome, or that it might require co-factors to manifest its full range of action. Orphanides et al. [10] also point to a mundane technical limitation of their experiment. Salt-gradient preparation of chromatin assembles nucleosomes unevenly and, in the limit, over-packs nucleosomes on DNA. The energetic cost of nucleosome displacement by RNA polymerase is mitigated by DNA-to-DNA nucleosome transfer, including transfer around the advancing RNA polymerase [11, 12] (Figure 2b ). Over-packing DNA with nucleosomes may interfere with factor-facilitated RNA chain elongation by preventing such transfer.
Although I have focused on FACT, I also want to refer the reader to two very interesting recent reports [13, 14] of evidence that the budding yeast proteins Spt4 and Spt5, which associate with polymerase II, contribute to normal RNA chain elongation in vivo, and that their human homologues confer sensitivity to the RNA-chain-elongation inhibitor 5,6-dichloro-1-D-ribofuranosylbenzimidazole on transcription by polymerase II in nuclear extracts. Persuasive, though indirect, arguments are marshalled to support the suggestion that these Spt proteins may play a role in helping polymerase II to surmount obstructionsincluding obstructions generated by chromatin -as it elongates RNA chains. However, experiments on chromatin transcription in vitro, comparable to those described for FACT, remain to be reported for this Spt complex.
These are fast-changing times in the quest to understand the critical interplay of chromatin structure, plasticity and modification with the transcription apparatus in the control of gene activity [7] [8] [9] 15] . With regard to the mechanism of RNA chain elongation on chromatin, one can convey a sense of the ideals and objectives of the search -at least from a biochemical perspective -and of the distance not yet traveled, by specifying the ultimate (hypothetical) in vitro reconstitution assay. This might combine a chromatin-embedded gene of appreciable length that responds to the various factors that work together to promote RNA chain elongation by polymerase II at an approximately in vivo rate (40-50 nucleotides per second on average). These would include enzymes such as histone acetyltransferases that modify higher-order nucleosome interactions; enzymes such as ATPases and protein kinases that mobilize nucleosome transfer along DNA; and elongation factors. Following the individual molecules of RNA polymerase in real time as they negotiate their nucleosome-strewn path along the gene will be especially interesting, because it will allow us to understand how the potential gridlock of chromatin transcription is resolved.
